Found: 14
Select item for more details and to access through your institution.
Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 6, p. 1, doi. 10.1038/s41419-021-03738-0
- By:
- Publication type:
- Article
Chronic myeloid leukaemia cells require the bone morphogenic protein pathway for cell cycle progression and self-renewal.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 9, p. 1, doi. 10.1038/s41419-018-0905-2
- By:
- Publication type:
- Article
Modulation of sialyl Lewis X dependent binding to E-Selectin by glycoforms of alpha-1-acid glycoprotein expressed in rheumatoid arthritis.
- Published in:
- Biomedical Chromatography, 1998, v. 12, n. 6, p. 343, doi. 10.1002/(SICI)1099-0801(199811/12)12:6<343::AID-BMC760>3.0.CO;2-6
- By:
- Publication type:
- Article
ANALYSIS OF IMATINIB IN BONE MARROW AND PLASMA SAMPLES OF CHRONIC MYELOID LEUKAEMIA PATIENTS USING SOLID PHASE EXTRACTION LC-ESI-MS.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2011, v. 24, n. 3, p. 285
- By:
- Publication type:
- Article
BCR- ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 4, p. 446, doi. 10.1111/j.1365-2141.2012.09078.x
- By:
- Publication type:
- Article
Investigation into omacetaxine solution stability for in vitro study.
- Published in:
- Biomedical Chromatography, 2012, v. 26, n. 5, p. 545, doi. 10.1002/bmc.1686
- By:
- Publication type:
- Article
The Emerging Role of H3K9me3 as a Potential Therapeutic Target in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00705
- By:
- Publication type:
- Article
Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-44771-9
- By:
- Publication type:
- Article
GAS2 Upregulation Is a Targetable Vulnerability in Chronic Myeloid Leukemia.
- Published in:
- International Journal of Translational Medicine, 2024, v. 14, n. 2, p. 354, doi. 10.3390/ijtm4020023
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5253, doi. 10.3390/cancers14215253
- By:
- Publication type:
- Article
A comparison of normal and leukemic stem cell biology in Chronic Myeloid Leukemia.
- Published in:
- Hematological Oncology, 2001, v. 19, n. 3, p. 89, doi. 10.1002/hon.667
- By:
- Publication type:
- Article
Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 2934, doi. 10.3390/jcm9092934
- By:
- Publication type:
- Article
Improved Efficacy of Quizartinib in Combination Therapy with PI3K Inhibition in Primary FLT3-ITD AML Cells.
- Published in:
- Italian Journal of Anatomy & Embryology / Archivio Italiano di Anatomia Ed Embriologia, 2022, v. 126, p. 309
- By:
- Publication type:
- Article